|
|
|
|
IMACS Group Meeting 2007
- 28-Oct-07
-
-
-- Joint Breakfast Meeting of the JDM Working Group and IMACS*
-
-- Saturday November 10, 2007; Time: 6:45 - 9:00 AM
-
-- Location: The Westin Boston Waterfront - Room: Commonwealth Ballroom Section A & B
-
-- All are invited, including trainees, clinical coordinators and nurses
- AGENDA
0645
Breakfast Service begins
|
0700 - 0745
MYOSITIS RESEARCH UPDATES
Moderators: Drs. Bianca Lang and David Isenberg
|
| 1. Cure JM |
Ms. Jacquelyne DenUyl |
| 2. The Myositis Association |
Mr. Bob Goldberg |
| 3. CARRA - JDM Practice Survey |
Dr. Brian Feldman |
| 4. PRINTO JDM Trial |
Dr. Nicola Ruperto |
| 5. JDM Diagnostic Criteria Study |
Dr. Clarissa Pilkington |
| 6. Myositis Classification Criteria Project |
Dr. Ingrid Lundberg |
| 7. Etanercept for Dermatomyositis Trial |
Dr. Anthony Amato |
| 8. Rituximab in Myositis (RIM) Trial |
Dr. Chester Oddis |
| 9. MITAX Computer Program |
Dr. David Isenberg |
| 10. IMACS Trials Repository |
Drs. Lisa Rider and Fred Miller |
0745 - 0900
MINISYMPOSIUM "THE ROLE OF INTERFERONS IN MYOSITIS PATHOGENESIS"
Moderators: Drs. Frederick Miller and Lisa Rider
|
| 1. Dendritic Cells in the Pathogenesis of Juvenile Dermatomyositis |
Dr. Ann Reed |
| 2. Scientific Rationale for the Interferon-Alpha Blockade in DM/PM |
Dr. Steven Greenberg |
| 3. Endogenous Activation of the Type I Interferon System in Myositis - A role for Anti-Jo 1 or Anti-Ro? |
Dr. Ingrid Lundberg |
| 4. Interferon response in JDM vs. SLE |
Dr. Virginia Pascual |
| 5. Relationship of Interferon Gene Expression to Disease Activity and Duration |
Dr. Lauren Pachman |
| 6. Anti-interferon alpha as a treatment for idiopathic inflammatory myopathy |
Dr. Gregory Dennis |
- The generous support of sponsors Wyeth/Amgen, The Myositis Association and the Cure JM Foundation is appreciated.
Program Updates
|
|
|
|